AVITA Medical's average Accounts Receivable for the
three
months ended in Mar. 2025 was $11.92 Mil. AVITA Medical's Revenue for the
three
months ended in Mar. 2025 was $18.51 Mil.
Hence, AVITA Medical's Days Sales Outstanding for the
three
months ended in Mar. 2025 was 58.73.
The historical rank and industry rank for AVITA Medical's Days Sales Outstanding or its related term are showing as below:
RCEL'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.61 Med: 53.95 Max: 490.16
Current: 50.85
During the past 13 years, AVITA Medical's highest Days Sales Outstanding was 490.16. The lowest was 34.61. And the median was 53.95.
RCEL's Days Sales Outstanding is ranked better than 70.49% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.905
vs RCEL: 50.85
AVITA Medical's Days Sales Outstanding
declined
from Mar. 2024 (60.59) to Mar. 2025 (58.73).
AVITA Medical Days Sales Outstanding Historical Data
The historical data trend for AVITA Medical's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of AVITA Medical's Days Sales Outstanding
For the Medical Devices subindustry, AVITA Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AVITA Medical's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where AVITA Medical's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVITA Medical (NAS:RCEL) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
AVITA Medical Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of AVITA Medical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RCEL has been successfully added to your 